Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam versus melatonin for prevention of ketamine-associated agitation
IRCT20180129038549N8Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in agitation comparing Midazolam plus ketamine, Melatonin plus ketamine and Placebo plus ketamine (3 arms). Primary endpoint: Richmond Agitation Scale. Started Mar 2017; status: completed.
02
Drugs
midazolammelatoninketamine
03
Conditions
agitation
Beyond the preview
Go deeper on IRCT20180129038549N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180129038549N8.